Airsculpt Technologies, Inc.(AIRS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Airsculpt Technologies, Inc. (AIRS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AIRS at 31.1/100 on a 32-signal composite quality model, placing it at rank #2,468 of 2,962 stocks — the bottom half of the AI-ranked universe. AIRS scores in the top quartile across institutional flow (79.6). Areas of concern include revenue growth (6.7) and revenue scale (20.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Airsculpt Technologies, Inc. reports quarterly revenue of $39.4M, net income of $-2.4M, an operating margin of -4.6%. Top institutional holders of AIRS by reported 13-F value include Vesey Street Capital Partners, L.L.C., THRIVENT FINANCIAL FOR LUTHERANS, BlackRock, based on the most recent SEC filings. AIRS trades on the Nasdaq exchange and files with the SEC under CIK 1870940. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AIRS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Airsculpt Technologies, Inc. directly from SEC EDGAR.

AI Quality Score

31.1/100

AI Rank

#2,468

Revenue

$39.4M

Net Income

$-2.4M

Free Cash Flow

$5.2M

Operating Margin

-4.6%

AIRS key financials by period

Airsculpt Technologies, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K/A$151.8M$-11.7M-7.6%
FY 202410-K/A$180.3M$-8.0M-0.9%
FY 202310-K/A$195.9M$-4.2M5.0%
FY 202210-K$168.8M$-14.7M-2.7%
FY 202110-K$133.3M$10.6M11.8%
FY 202010-K$62.8M$7.6M16.0%

Institutions holding AIRS

Institutional investors reporting a position in Airsculpt Technologies, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Vesey Street Capital Partners, L.L.C.30,324,180$136.5M2026-06-30
THRIVENT FINANCIAL FOR LUTHERANS4,425,000$19.9M2026-06-30
BlackRock1,278,871$5.8M2026-06-30
WEXFORD CAPITAL841,734$3.8M2026-06-30
UBS Group AG792,183$3.6M2026-06-30
FourWorld Capital Management750,000$3.4M2026-06-30
FLPUTNAM INVESTMENT MANAGEMENT691,989$3.1M2026-06-30
AQR CAPITAL MANAGEMENT470,723$2.1M2026-06-30
GEODE CAPITAL MANAGEMENT451,224$2.0M2026-06-30
GSA CAPITAL PARTNERS LLP425,186$1.9M2026-06-30
AIRS

Airsculpt Technologies, Inc.

AIRS
NasdaqSmall CapHealthcare

13F Pro Quality Score

31.1/100

Rank #2,468 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

6.7/100

Profitability

26.6/100

Balance Sheet

21.9/100

Earnings Quality

58.2/100

Free Cash Flow

40.6/100

Institutional Flow

79.6/100

Revenue Scale

20.2/100

Dilution Risk

45.8/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q1 2026
EDGAR

$39.39M

Net Income

Q1 2026
EDGAR

$-2.40M

EPS (Diluted)

Q1 2026
EDGAR

$-0.03

Operating Margin

Q1 2026
EDGAR

-4.6%

ROIC

Q1 2026
EDGAR

-4.8%

Free Cash Flow

Q1 2026
EDGAR

$5.22M

Debt/Equity

Q1 2026
EDGAR

0.50

Top Institutional Holders

as of Q2 2026
$208.21M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…